Back
Cementos Pacasmayo SAA Vs. Viking Therapeutics Industry Stock Comparison
Sell
50
CPAC
Cementos Pacasmayo SAA
Last Price:
5.70
Seasonality Move:
-4.52%
Sell
44
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Sell
50
Cementos Pacasmayo SAA (CPAC)
is a Sell
Is Cementos Pacasmayo SAA a Buy, Sell or Hold?
- The current Cementos Pacasmayo SAA [CPAC] share price is $5.77. The Score for CPAC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CPAC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPAC Stock Price Chart
What is Cementos Pacasmayo SAA's stock price today?
-
The Cementos Pacasmayo SAA share price today is $5.77
The current trend is moderately bullish and CPAC is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CPAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 59.38 | Buy |
| Chaikin Money Flow: | -379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.54 - 5.7) | Buy |
| Bollinger Bands (100): | (5.22 - 5.98) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.32 | Sell |
| Relative Strength Index (14 RSI): | 38.16 | Sell |
| Chaikin Money Flow: | 2857375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.57 - 61.31) | Sell |
| Bollinger Bands (100): | (46.52 - 79.44) | Sell |
CPAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.68 | Buy |
| 20-day SMA: | 5.64 | Buy |
| 50-day SMA: | 5.52 | Buy |
| 200-day SMA: | 5.33 | Buy |
| 8-day EMA: | 5.69 | Buy |
| 20-day EMA: | 5.64 | Buy |
| 50-day EMA: | 5.59 | Buy |
| 200-day EMA: | 5.43 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.48 | Buy |
| 20-day SMA: | 54.1 | Sell |
| 50-day SMA: | 63.93 | Sell |
| 200-day SMA: | 39 | Buy |
| 8-day EMA: | 50.61 | Buy |
| 20-day EMA: | 54.34 | Sell |
| 50-day EMA: | 59.63 | Sell |
| 200-day EMA: | 45.62 | Buy |
Cementos Pacasmayo SAA Earnings Growth & CPAC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Cementos Pacasmayo SAA Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||